首页 | 本学科首页   官方微博 | 高级检索  
     

固肾1号对膜性肾小球肾炎的治疗作用
引用本文:陈芙蓉,姜溪,只德广,岳南. 固肾1号对膜性肾小球肾炎的治疗作用[J]. 现代药物与临床, 2014, 37(4): 326-332
作者姓名:陈芙蓉  姜溪  只德广  岳南
作者单位:天津药物研究院新药安全评价研究中心, 天津 300193;天津药物研究院新药安全评价研究中心, 天津 300193;天津药物研究院新药安全评价研究中心, 天津 300193;天津药物研究院新药安全评价研究中心, 天津 300193
摘    要:目的 观察固肾1号对膜性肾小球肾炎的影响,并探讨其可能的作用机制。方法 采用家兔C-BSA膜性肾炎模型和大鼠主动Heymann模型,观察固肾1号对尿蛋白定量、血液生化、肾脏系数、肾脏病理的影响。结果 固肾1号能显著降低(24 h)尿蛋白定量,降低血清尿素氮(BUN)、肌酐(Cr)水平,升高血清总蛋白(Tp)、白蛋白(Alb)水平,并能降低肾脏系数,减轻肾脏病变。结论 固肾1号对膜性肾小球肾炎有明显的防治作用。

关 键 词:膜性肾炎  肾小球肾炎  阳离子化牛血清白蛋白  Heymann肾炎
收稿时间:2014-02-12

Therapeutic effect of Gushen 1 on membraneous glomerulo nephritis
CHEN Fu-rong,JIANG Xi,ZHI De-guang and YUE Nan. Therapeutic effect of Gushen 1 on membraneous glomerulo nephritis[J]. Drugs & Clinic, 2014, 37(4): 326-332
Authors:CHEN Fu-rong  JIANG Xi  ZHI De-guang  YUE Nan
Affiliation:Center for Drug Evaluation and Research, Tianjin Institute of Pharmaceutical Reseach, Tianjin 300193, China;Center for Drug Evaluation and Research, Tianjin Institute of Pharmaceutical Reseach, Tianjin 300193, China;Center for Drug Evaluation and Research, Tianjin Institute of Pharmaceutical Reseach, Tianjin 300193, China;Center for Drug Evaluation and Research, Tianjin Institute of Pharmaceutical Reseach, Tianjin 300193, China
Abstract:Objective To investigate the effect of Gushen 1 on the membranous glomerulonephritis and detect its possible mechanisms. Methods C-BSA membranous nephritis of rabbitss induced by administration of an exogenous cationic antigen and active Heymann nephritis of rats induced by immunization with renal cortex were used to observe the therapeutic effect of Gushen 1 on urine protein, blood biochemistry, kidney index, and kidney pathology. Results Gushen 1 could significantly reduce 24 h surine protein, serum urea nitrogen, and serum creatinine, while increase the levels of serum total protein and albumin. A significant reducing of renal index and improvement of kidney pathology were observed in the group of Gushen1compared to the model group. Conclusion It is obvious that Gushen 1 could improve the kidney pathology and be used for the treatment of membranous glomerulonephritis.
Keywords:membranous nephritis  glomerulonephritis  C-BSA  Heymann nepharitis
点击此处可从《现代药物与临床》浏览原始摘要信息
点击此处可从《现代药物与临床》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号